Assessment of the hypothalamic-pituitary-adrenal axis activity: Glucocorticoid receptor and mineralocorticoid receptor function in depression with early life stress - A systematic review

Acta Neuropsychiatrica

Volumn 24, Issue 1, 2012, Pages 4-15

  Von Werne Baes, Cristiane ^a   De Carvalho Tofoli, Sandra M ^a   Martins, Camila Maria S ^a   Juruena, Mario F ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

affective disorder; corticoids; cortisol; hypothalmo pituitary adrenal axis; neuroendocrinology; pituitary gland; stress

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; FLUDROCORTISONE; GLUCOCORTICOID RECEPTOR; MINERALOCORTICOID RECEPTOR; PREDNISOLONE; SPIRONOLACTONE;

ADULT; CHILD ABUSE; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; EARLY LIFE STRESS; HUMAN; HYPERCORTISOLISM; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR DEPRESSION; MEDLINE; PROTEIN FUNCTION; PSYCHOPHYSIOLOGY; REVIEW; SYSTEMATIC REVIEW;

EID: 84856403497     PISSN: 09242708     EISSN: 16015215     Source Type: Journal    
DOI: 10.1111/j.1601-5215.2011.00610.x     Document Type: Review

References (64)

1. Kendler KS, Sheth K, Gardner CO, Prescott CA., Childhood parental loss and risk for first-onset of major depression and alcohol dependence: the time-decay of risk and sex differences. Psychol Med 2002; 32: 1187-1194. (Pubitemid 35243976)
2. Heim C, Newport DJ, Heit S, et al., Pituitary-adrenal and autonomic responses to stress in women after sexual and physical abuse in childhood. JAMA 2000; 284: 592-597. (Pubitemid 30622145)
3. Fergusson DM, Swain-Campbell NR, Horwood LJ., Does sexual violence contribute to elevated rates of anxiety and depression in females? Psychol Med 2002; 32: 991-996.
4. Cohen P, Brown J, Smailes E., Child abuse and neglect and the development of mental disorders in the general population. Dev Psychopathol 2001; 13: 981-999. (Pubitemid 33580428)
5. Post RM., Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. Am J Psychiatry 1992; 149: 999-1010.
6. Shea A, Walsh C, Macmillan H, Steiner M., Child maltreatment and HPA axis dysregulation: relationship to major depressive disorder and post traumatic stress disorder in females. Psychoneuroendocrinology 2005; 30: 162-178. (Pubitemid 39313113)
7. Mello AAF, Mello MF, Carpenter LL, Price LH., Update on stress and depression: the role of the hypothalamic-pituitary-adrenal (HPA) axis. Rev Bras Psiquiatr 2003; 25: 231-238. (Pubitemid 37376769)
8. Parker KJ, Schatzberg AF, Lyons DM., Neuroendocrine aspects of hypercortisolism in major depression. Horm Behavr 2003; 43: 60-66. (Pubitemid 36293275)
9. Juruena MF, Cleare AJ, Pariante CM., The hypothalamic pituitary adrenal axis, glucocorticoid receptor function and relevance to depression. Rev Bras Psiquiatr 2004; 26: 189-201. (Pubitemid 39273846)
10. Carroll BJ, Cassidy F, Naftolowitz D, et al., Pathophysiology of hypercortisolism in depression. Acta Psychiatr Scand 2007; 115 (Suppl. 433): 90-103. (Pubitemid 46114844)
11. Pariante CM., The glucocorticoid receptor: part of the solution or part of the problem? J Psychopharmacol 2006; 20: 79-84. (Pubitemid 44576663)
12. Pariante CM, Miller AH., Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment. Biol Psychiatry 2001; 49: 391-404. (Pubitemid 32234301)
13. Herman JP, Patel PD, Akil H, Watson S., Localization and regulation of glucocorticoid and mineralocorticoid receptor messenger RNAs in the hippocampal formation of the rat. Mol Endocrinol 1989; 3: 1886-1894. (Pubitemid 20003675)
14. Patel PD, Lõpez JF, Lyons DM, Burke S, Wallace M, Schatzberg AF., Glucocorticoid and mineralocorticoid receptor mRNA expression in squirrel monkey brain. J Psychiatr Res 2000; 34: 383-392. (Pubitemid 32103282)
15. de Kloet ER, Vreugdenhil E, Oitzl MS, Joels M., Brain corticosteroid receptor balance in health and disease. Endocr Rev 1998; 19: 269-301. (Pubitemid 29117816)
16. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H., Normal pituitary response to metyrapone in the morning in depressed patients: implications for circadian regulation of CRH secretion. Biol Psychiatry 1997; 41: 1149-1155. (Pubitemid 27237175)
17. Carroll BJ, Curtis GC, Mendels J., Neuroendocrine regulation in depression. II. Discrimination of depressed from nondepressed patients. Arch Gen Psychiatry 1976; 33: 1051-1058.
18. Arana G, Baldessarini R, Ornsteen M., The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry 1985; 42: 1192-1204.
19. Ribeiro SC, Tandon R, Grunhaus L, Greden JF., The DST as a predictor of outcome in depression: a meta-analysis. Am J Psychiatry 1993; 150: 1618-1629. (Pubitemid 23325942)
20. Pariante CM, Papadopoulos AS, Poon L, et al., A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis. Biol Psychiatry 2002; 51: 922-930. (Pubitemid 34521941)
21. von Bardeleben U, Holsboer F., Effect of age on the cortisol response to human corticotropin-releasing hormone in depressed patients pretreated with dexamethasone. Biol Psychiatry 1991; 29: 1042-1050.
22. Heuser I, Yassouridis A, et al., The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 1994; 28: 341-356. (Pubitemid 24370022)
23. Zobel AW, Nickel T, Sonntag A, Uhr M, Holsboer F, Ising M., Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study. J Psychiatr Res 2001; 35: 83-94. (Pubitemid 32506751)
24. Grossmann C, Scholz T, Rochel M, et al., Transactivation via the human glucocorticoid and mineralocorticoid receptor by therapeutically used steroids in CV-1 cells: a comparison of their glucocorticoid and mineralocorticoid properties. Eur J Endocrinol 2004; 151: 397-406. (Pubitemid 39307329)
25. Ballard PL, Carter JP, Graham BS, Baxter JD., A radioreceptor assay for evaluation of the plasma glucocorticoid activity of natural and synthetic steroids in man. J Clin Endocrinol Metab 1975; 41: 290-304.
26. Heuser I, Deuschle M, Weber B, Stalla GK, Holsboer F., Increased activity of the hypothalamus-pituitary-adrenal system after treatment with the mineralocorticoid receptor antagonist spironolactone. Psychoneuroendocrinology 2000; 25: 513-518. (Pubitemid 30249195)
27. Holsboer F., The rationale for corticotropin-releasing hormone receptor (CRH-R) antagonists to treat depression and anxiety. J Psychiatr Res 1999; 33: 181-214. (Pubitemid 29178663)
28. Otte C, Hinkelmann K, Moritz S, Yassouridis A, Jahn H, Wiedemann K, Kellner M., Modulation of the mineralocorticoid receptor as add-on treatment in depression: a randomized, double-blind, placebo-controlled proof-of-concept study. J Psychiatr Res 2010; 44: 339-346.
29. Carpenter LL, Ross NS, Tyrka AR, Anderson GM, Kelly M, Price LH., Dex/CRH test cortisol response in outpatients with major depression and matched healthy controls. Psychoneuroendocrinology 2009; 34: 1208-1213.
30. Heim C, Mletzko T, Purselle D, Musselman DL, Nemeroff CB., The dexamethasone/corticotropin-releasing factor test in men with major depression: role of childhood trauma. Biol Psychiatry 2008; 63: 398-405.
31. Kunugi H, Ida I, Owashi T, et al., Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study. Neuropsychopharmacology 2006; 31: 212-220. (Pubitemid 43250958)
32. Gervasoni N, Bertschy G, Osiek C, et al., Cortisol responses to combined dexamethasone/CRH test in outpatients with a major depressive episode. J Psychiatr Res 2004; 38: 553-557. (Pubitemid 39348886)
33. Pfennig A, Kunzel HE, Kern N, et al., Hypothalamus-pituitary-adrenal system regulation and suicidal behavior in depression. Biol Psychiatry 2005; 57: 336-342. (Pubitemid 40215762)
34. Kunugi H, Urushibara T, Nanko S., Combined DEX/CRH test among Japanese patients with major depression. J Psychiatr Res 2004; 38: 123-128. (Pubitemid 38134452)
35. Van Den Eede F, Van den Bossche B, Hulstijn W, Sabbe BG, Cosyns P, Claes SJ., Combined dexamethasone/CRF test in remitted outpatients with recurrent major depressive disorder. J Affect Disord 2006; 93: 259-263. (Pubitemid 43833249)
36. Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K., Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression. Psychoneuroendocrinology 2008; 33: 152-161.
37. Oshima A, Yamashita S, Owashi T, et al., The differential ACTH responses to combined dexamethasone/CRH administration in major depressive and dysthymic disorders. J Psychiatr Res 2000; 34: 325-328.
38. Duval F, Mokrani MC, Correa H, et al., Lack of effect of HPA axis hyperactivity on hormonal responses to d-fenfluramine in major depressed patients: implications for pathogenesis of suicidal behaviour. Psychoneuroendocrinology 2001; 26: 521-537. (Pubitemid 32402218)
39. Nunes SOV, Reiche EMV, Morimoto HK, et al., Immune and hormonal activity in adults suffering from depression. Braz J Med Biol Res 2002; 35: 581-587. (Pubitemid 34568226)
40. Galard R, Catalán R, Castellanos JM, Gallart JM., Plasma corticotropin-releasing factor in depressed patients before and after the dexamethasone suppression test. Biol Psychiatry 2002; 51: 463-468. (Pubitemid 34260966)
41. Vreeburg SA, Hoogendijk WJ, van Pelt J, et al., Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study. Arch Gen Psychiatry 2009; 66: 617-626.
42. Pitchot W, Scantamburlo G, Pinto E, Hansenne M, Reggers J, Ansseau M, Legros JJ., Vasopressin-neurophysin and DST in major depression: relationship with suicidal behavior. J Psychiatr Res 2008; 42: 684-688. (Pubitemid 351626060)
43. Jokinen J, Nordström P., HPA axis hyperactivity and attempted suicide in young adult mood disorder inpatients. J Affect Disord 2009; 116: 117-120.
44. Fountoulakis KN, Iacovides A, Fotiou F, et al., Neurobiological and psychological correlates of suicidal attempts and thoughts of death in patients with major depression. Neuropsychobiology 2004; 49: 42-52. (Pubitemid 38134867)
45. Fountoulakis KN, Gonda X, Rihmer Z, Fokas C, Iacovides A., Revisiting the dexamethasone suppression test in unipolar major depression: an exploratory study. Ann Gen Psychiatry 2008; 7: 22.
46. Gaudiano BA, Epstein-Lubow G, Miller IW., Does the dexamethasone suppression test reliably discriminate between psychotic and nonpsychotic major depression?: an exploratory analysis of potential confounds. J Nerv Ment Dis 2009; 197: 395-400.
47. Contreras F, Menchon JM, Urretavizcaya M, Navarro MA, Vallejo J, Parker G., Hormonal differences between psychotic and non-psychotic melancholic depression. J Affect Disord 2007; 100: 65-73. (Pubitemid 46818427)
48. Stewart JW, Quitkin FM, McGrath PJ, Klein DF., Defining the boundaries of atypical depression: evidence from the HPA axis supports course of illness distinctions. J Affect Disord 2005; 86: 161-167. (Pubitemid 40780028)
49. Levitan RD, Vaccarino FJ, Brown GM, Kennedy SH., Low-dose dexamethasone challenge in women with atypical major depression: pilot study. J Psychiatry Neurosci 2002; 27: 47-51. (Pubitemid 34478369)
50. Stetler C, Miller GE., Depression and hypothalamic-pituitary-adrenal activation: a quantitative summary of four decades of research. Psychosomatic Medicine 2011; 73: 114-126.
51. Watson S, Gallagher P, Del-Estal D, Hearn A, Ferrier IN, Young AH., Hypothalamic-pituitary-adrenal axis function in patients with chronic depression. Psychol Med 2002; 32: 1021-1028.
52. Watson S, Gallagher P, Smith MS, Ferrier IN, Young AH., The dex/CRH test-is it better than the DST? Psychoneuroendocrinology 2006; 31: 889-894. (Pubitemid 43949442)
53. Paslakis G, Krumma B, Gilles M, Schweiger U, Heuser I, Inga Richter I, Deuschle M., Discrimination between patients with melancholic depression and healthy controls: Comparison between 24-h cortisol profiles, the DST and the Dex/CRH test. Psychoneuroendocrinology 2011; 36: 691-698.
54. Juruena MF, Pariante CM, Papadoulos AS, Poon L, Lightman S, Cleare AJ., Prednisolone suppression test in depression: prospective study of the role of HPA axis dysfunction in treatment resistance. Br J Psychiatry 2009; 194: 342-349.
55. Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Ligtman S, Pariante CM., The prednisolone suppression test in depression: dose-response and changes with antidepressant treatment. Psychoneuroendocrinology 2010; 35: 1485-1491.
56. Juruena MF, Cleare AJ, Papadopoulos AS, Poon L, Lightman S, Pariante CM., Different responses to dexamethasone and prednisolone in the same depressed patients. Psychopharmacology 2006; 189: 225-235. (Pubitemid 44691544)
57. Buckley TM, Mullen BC, Schatzberg AF., The acute effects of a mineralocorticoid receptor (MR) agonist on nocturnal hypothalamic-adrenal- pituitary (HPA) axis activity in healthy controls. Psychoneuroendocrinology 2007; 32: 859-864. (Pubitemid 350086798)
58. Young EA, Lopez JF, Murphy-Weinberg V, Watson SJ, Akil H., Mineralocorticoid receptor function in major depression. Arch Gen Psychiatry 2003; 60: 24-28. (Pubitemid 36070861)
59. Carpenter LL, Tyrka AR, Ross NS, Khoury L, Anderson GM, Price LH., Effect of childhood emotional abuse and age on cortisol responsivity in adulthood. Biol Psychiatry 2009; 66: 69-75.
60. Klaassens ER, van Noorden MS, Giltay EJ, van Pelt J, van Veen T, Zitman FG., Effects of childhood trauma on HPA-axis reactivity in women free of lifetime psychopathology. Prog Neuropsychopharmacology Biol Psychiatry 2009; 33: 889-894.
61. Newport DJ, Heim C, Bonsall R, Miller AH, Nemeroff CB., Pituitary-adrenal responses to standard and low-dose dexamethasone suppression tests in adult survivors of child abuse. Biol Psychiatry 2004; 55: 10-20. (Pubitemid 38045428)
62. Tyrka AR, Wier L, Price LH, Ross N, Anderson GM, Wilkinson CW, Carpenter LL., Childhood parental loss and adult hypothalamic-pituitary-adrenal function. Biol Psychiatry 2008; 63: 1147-1154.
63. Spencer RL, Kim PJ, Kalman BA, Cole MA., Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity. Endocrinology 1998; 139: 2718-2726. (Pubitemid 28512379)
64. Mello AF, Juruena MF, Pariante CM, et al., Depressão e estresse: existe um endofenõtipo? Rev Bras Psiquiatr 2007; 29 (Suppl. I): 13-18.